Market Tracker

12/11 6:02am ET

Emergent BioSolutions Inc (NYSE:EBS)

43.55
Delayed Data
As of Dec 08
 +1.13 / +2.66%
Today’s Change
26.16
Today|||52-Week Range
44.97
+32.61%
Year-to-Date
Six Off the Beaten Path Healthcare Stock Gems
Dec 09 / TheStreet.com - Paid Partner Content
New Strong Buy Stocks for December 1st
Dec 01 / Zacks.com - Paid Partner Content
Vertex Kalydeco Study Successful in Children Aged 1-2 Years
Dec 08 / Zacks.com - Paid Partner Content
New Strong Buy Stocks for November 28th
Nov 28 / Zacks.com - Paid Partner Content
4 Biotech Stocks to Better Your Financial Health This Winter
Dec 01 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close42.42
Today’s open43.26
Day’s range42.50 - 43.89
Volume576,204
Average volume (3 months)373,379
Market cap$1.8B
Dividend yield--
Data as of 4:02pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+21.33%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio25.6
Price/Sales3.31
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...+0.60+1.36%
INVAInnoviva Inc+0.12+0.93%
MYOKMyoKardia Inc+2.20+5.94%
LXRXLexicon Pharmaceutic...+0.56+5.66%
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateMarch 8, 2018
EPS forecast (this quarter)$0.59
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts